Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Director | January 26, 2026 | January 28, 2026 |
| ORAGENICS INCOGEN · Entity 8495 | Director | December 11, 2025 | December 15, 2025 |
| PALATIN TECHNOLOGIES INCPTN · Entity 7649 | Director | August 03, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 26, 2026 · Filed January 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,703 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Grant · Acquired 30,453 · Balance 70,703 F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.
ORAGENICS INC
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Employee Director Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2035-12-11 | Direct | 125,000 |
Reported balance
After 2025-12-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-11 · Grant · Acquired 125,000 · Balance 125,000 F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.
PALATIN TECHNOLOGIES INC
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| StockOption (Right toBuy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.70 · Expires 2037-08-03 | Direct | 25,769 |
Reported balance
After 2026-08-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-03 · Other · Acquired 2,200 · Balance 25,769 F1: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2020 Filed Feb 28, 2020 02:32 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 15,000 | $5.63 Strike: $5.63 | $84,450.00 |
DisclosureSEC source: 0001213900-20-004972 · doc4.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-02-25 F2 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:21 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 156,540 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-20-001786 · ownership.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,540 Underlying: Common Stock · 156,540 shares Expires 2030-02-05 F2 · security: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. F2 · shares: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. F2 · derivative.underlying_shares: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. F2 · balance_after: Represents a discretionary retention award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's Plan. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 5, 2020. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:21 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 156,540 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-20-001786 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,540 Underlying: Common Stock · 156,540 shares Expires 2030-02-05 F1 · security: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. F1 · shares: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. F1 · balance_after: Represents an annual award of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended (the "Plan") that vests immediately. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:06 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 7,500 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001654954-19-008296 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-07-12 F2 · derivative.exercise_date: These options were granted on 7/12/2019. The options vest monthly with 100% vesting on the one-year anniversary of the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:06 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-19-008296 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 F1 · price: These Restricted Stock Units were granted on 7/12/2019. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest monthly with 100% vesting on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001654954-19-007686 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2029-06-24 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:38 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-19-007686 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,685 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 24, 2020. Read SEC document |
| June 20, 2019 Filed Jun 24, 2019 21:05 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 156,540 | Not disclosed Strike: $0.48 | Not disclosed |
DisclosureSEC source: 0000899243-19-017957 · doc4.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,540 Underlying: Common Stock · 156,540 shares Expires 2029-06-20 F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F1 · price: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F1 · derivative.underlying_shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:06 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 100,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001654954-19-002247 · section16.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: These options were granted on 3/1/2019. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| March 01, 2019 Filed May 9, 2019 20:07 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $8.50 | $0.00 |
DisclosureSEC source: 0001654954-19-005559 · section16.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: The vesting of the options was incorrectly reported in the original filing. F2 · derivative.exercise_date: These options were granted on 3/1/2019. The options vest one-third on the date of grant, one-third on the first anniversary of the date of grant and one-third on the second anniversary of the date of grant. Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 21:18 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseCommon Stock | 1,000 | $0.80 | $800.00 |
DisclosureSEC source: 0001654954-18-012956 · section16.xml · nonDerivative · entry 4 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,351 Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 21:18 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseCommon Stock | 4,000 | $0.77 | $3,068.40 |
DisclosureSEC source: 0001654954-18-012956 · section16.xml · nonDerivative · entry 3 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,351 Read SEC document |
| November 16, 2018 Filed Nov 19, 2018 21:18 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseCommon Stock | 5,000 | $0.78 | $3,900.00 |
DisclosureSEC source: 0001654954-18-012956 · section16.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,351 Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:18 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseCommon Stock | 332 | $0.80 | $265.60 |
DisclosureSEC source: 0001654954-18-012956 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,351 Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 20:06 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0000899243-18-025658 · doc4.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-09-27 F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018. F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018. Read SEC document |
| July 17, 2018 Filed Jul 17, 2018 20:44 UTC | ORAGENICS INC OGEN · Entity 8495 | PurchaseCommon Stock Warrants (right to buy) · Derivative | 20,000 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0000899243-18-019955 · doc4.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-07-17 F1 · price: Purchase of Class A Units consisting of one share of common stock and one warrant to purchase one share of common stock in an underwritten public offering at the price of $1.00 per Unit, which was the price paid by the public for such Units. Read SEC document |
| July 17, 2018 Filed Jul 17, 2018 20:44 UTC | ORAGENICS INC OGEN · Entity 8495 | PurchaseCommon Stock | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-019955 · doc4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,261 F1 · price: Purchase of Class A Units consisting of one share of common stock and one warrant to purchase one share of common stock in an underwritten public offering at the price of $1.00 per Unit, which was the price paid by the public for such Units. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 20:39 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (right to buy) · Derivative | 28,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001654954-18-007106 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2028-06-26 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2018. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 20:39 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-007106 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,353 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 26, 2019. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 26, 2019. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 20:39 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0000899243-18-018151 · doc4.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-06-22 F2 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest one year from the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2018. F2 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest one year from the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2018. Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 20:39 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-018151 · doc4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,261 F1 · shares: Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests immediately. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:25 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001654954-17-011595 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-12-12 F2 · derivative.exercise_date: The options vest at the rate of one-third per year, starting on December 12, 2018. Read SEC document |
| December 12, 2017 Filed Dec 13, 2017 21:25 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-17-011595 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,520 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of one-third per year starting on December 12, 2018. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest at the rate of one-third per year starting on December 12, 2018. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 19:27 UTC | ORAGENICS INC OGEN.BC · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0000899243-17-017196 · doc4.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2027-06-22 F1 · shares: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017. F1 · balance_after: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2017. Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 20:16 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (right to buy) · Derivative | 54,000 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001654954-17-005810 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2027-06-20 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2017. Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 20:16 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 54,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-17-005810 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,520 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2018. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2018. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 21:05 UTC | ORAGENICS INC OGEN.BC · Entity 8495 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-003781 · doc4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,588 F1 · balance_after: Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests equally over each of the four calendar quarters during 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.